Loncarevic I - Search Results

1

Characteristic genomic imbalances in pediatric pheochromocytoma.

Hering A, Guratowska M, Bucsky P, Claussen U, Decker J, Ernst G, Hoeppner W, Michel S, Neumann H, Parlowsky T, Loncarevic I. Hering A, et al. Among authors: loncarevic i. Genes Chromosomes Cancer. 2006 Jun;45(6):602-7. doi: 10.1002/gcc.20323. Genes Chromosomes Cancer. 2006. PMID: 16518846

2

Number of genomic imbalances correlates with the overall survival for adrenocortical cancer in childhood.

Loncarevic IF, Hering A, Posorski N, Linden T, Hoyer H, Bucsky P. Loncarevic IF, et al. Pediatr Blood Cancer. 2008 Sep;51(3):356-62. doi: 10.1002/pbc.21603. Pediatr Blood Cancer. 2008. PMID: 18478573

3

Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.

Loncarevic IF, Römer J, Starke H, Heller A, Bleck C, Ziegler M, Fiedler W, Liehr T, Clement JH, Claussen U. Loncarevic IF, et al. Genes Chromosomes Cancer. 2002 Jun;34(2):193-200. doi: 10.1002/gcc.10056. Genes Chromosomes Cancer. 2002. PMID: 11979553

4

Breakpoint differentiation in chromosomal aberrations of hematological malignancies: Identification of 33 previously unrecorded breakpoints.

Heller A, Loncarevic IF, Glaser M, Gebhart E, Trautmann U, Claussen U, Liehr T. Heller A, et al. Int J Oncol. 2004 Jan;24(1):127-36. Int J Oncol. 2004. PMID: 14654949

5

A long distance-PCR derived FISH probe detects a deletion between p15 and p16 in CML and T-ALL patients.

Bleichert A, Fiedler W, Claussen U, Ernst G, Loncarevic IF, Heller A, Liehr T, Kunert C, von Eggeling F. Bleichert A, et al. Among authors: loncarevic if. Int J Mol Med. 2001 Jun;7(6):591-5. doi: 10.3892/ijmm.7.6.591. Int J Mol Med. 2001. PMID: 11351270

6

Complex chromosomal rearrangements in a secondary acute myeloblastic leukemia after chemotherapy in TRAPS.

Heller A, Trifonov V, Rubtsov N, Sauerbrey A, Starke H, Loncarevic IF, Claussen U, Liehr T. Heller A, et al. Oncol Rep. 2003 Nov-Dec;10(6):1789-92. doi: 10.3892/or.10.6.1789. Oncol Rep. 2003. PMID: 14534697

7

Characterization of a highly aberrant plasma cell leukemia karyotype: a case report.

Heller A, Fricke HJ, Starke H, Loncarevic IF, Claussen U, Liehr T. Heller A, et al. Oncol Rep. 2004 Jan;11(1):89-92. Oncol Rep. 2004. PMID: 14654908

8

A complex translocation event between the two homologues of chromosomes 5 leading to a del(5)(q21q33) as a sole aberration in a case clinically diagnosed as CML: characterization of the aberration by multicolor banding.

Heller A, Starke H, Trifonov V, Rubtsov N, Wedding U, Loncarevic I, Bleck C, Claussen U, Liehr T. Heller A, et al. Among authors: loncarevic i. Int J Oncol. 2002 Jun;20(6):1179-81. Int J Oncol. 2002. PMID: 12011996

9

Immune escape for renal cell carcinoma: CD70 mediates apoptosis in lymphocytes.

Diegmann J, Junker K, Loncarevic IF, Michel S, Schimmel B, von Eggeling F. Diegmann J, et al. Neoplasia. 2006 Nov;8(11):933-8. doi: 10.1593/neo.06451. Neoplasia. 2006. PMID: 17132225 Free PMC article.

10

Tapping an unexploited repository: Carnoy's fixed cell pellets for proteomic biomarker research in leukemia.

Von Eggeling F, Bleul A, Loncarevic IF, Michel S, Heller A, Melle C. Von Eggeling F, et al. Mol Med Rep. 2008 Jul-Aug;1(4):585-7. Mol Med Rep. 2008. PMID: 21479455

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters